Potrero Medical, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Potrero Medical, Inc.
Deal Snapshot: Other major players have made headway in bispecifics for prostate cancer, while Jemincare’s drug is the latest China-developed technology to head westward.
Potrero Medical Inc. has enhanced a standard urinary drainage catheter to provide clinicians with critical physiological data to enable earlier detection of sepsis. The multi-lumen Accuryn catheter is able to track and trend in real time six clinical parameters: urine output, temperature, heart rate, respiratory rate, intra-abdominal pressure, and relative stroke volume, and thus identify the signature physiological changes that occur with sepsis.
This month's profiles: InPress Technologies, MaRVis Medical, Medherant, Molecular Assemblies, MyoPowers, Potrero Medical, Revolution Medicines, and Rivanna Medical
Immunexpress' SeptiCyte system is designed to directly quantify molecular markers of sepsis from patient blood samples and within a few hours detect the probability that a patient has sepsis, allowing for aggressive treatment, or if the test result is negative, preventing unnecessary antibiotics.
- Medical Devices
- Consumables, Central Supplies
- Implantable Devices
- Infection Control-Sterilization
- Infusion Therapy Equipment and Supplies
- Monitoring Equipment & Devices
- Radiofrequency Devices
- Rehabilitation Equipment and Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
Diagnostic Imaging Equipment & Supplies
- Digital Imaging
- Artificial Intelligence